Aaron P Mitchell
Overview
Explore the profile of Aaron P Mitchell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
181
Citations
6813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim M, Mitchell A
mSphere
. 2025 Jan;
10(1):e0098024.
PMID: 39745385
Importance: is a widespread fungal pathogen. The regulatory circuitry underlying virulence traits is well studied in the reference strain background, but not in other clinical isolate backgrounds. Here, we describe...
2.
Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policy
Saririan N, Bhamidipati D, Dey P, Persaud S, Chakraborty N, Tabatabai S, et al.
JNCI Cancer Spectr
. 2024 Nov;
8(6).
PMID: 39589914
Background: The National Comprehensive Cancer Network (NCCN) financial conflict of interest (FCOI) policy sets dollar maximums for panelists, but violations may occur. Methods: We studied NCCN Guidelines panelists for the...
3.
Kim M, White A, Mitchell A
mSphere
. 2024 Oct;
9(11):e0057924.
PMID: 39431903
Central carbon metabolism is vital for the proliferation of , a fungus that is prominent as a commensal and pathogen. Glycolytic genes are activated by overlapping activities of the transcription...
4.
Mitchell A, Persaud S, Mishra Meza A, Fuchs H, De P, Tabatabai S, et al.
J Clin Oncol
. 2024 Oct;
43(5):524-535.
PMID: 39393041
Purpose: The Medicare part D Low-Income Subsidy (LIS) improves access to oral cancer drugs, but provides no assistance for clinician-administered/part B drugs. This analysis assessed the association between LIS participation...
5.
Kim M, Cravener M, Solis N, Filler S, Mitchell A
mBio
. 2024 Jul;
15(9):e0187224.
PMID: 39078139
Major virulence traits include its ability to make hyphae, to produce a biofilm, and to damage host cells. These traits depend upon expression of hypha-associated genes. A gene expression comparison...
6.
Xiong L, Goerlich K, Do E, Mitchell A
mSphere
. 2024 Jul;
9(7):e0037224.
PMID: 38980069
Iron acquisition is critical for pathogens to proliferate during invasive infection, and the human fungal pathogen is no exception. The iron regulatory network, established in reference strain SC5314 and derivatives,...
7.
Chakraborty N, Brown M, Persaud S, Gallagher G, Trivedi N, Bach P, et al.
JNCI Cancer Spectr
. 2024 Jun;
8(3).
PMID: 38825338
Background: Industry payments to US cancer centers are poorly understood. Methods: US National Cancer Institute (NCI)-designated comprehensive cancer centers were identified (n = 51). Industry payments to NCI-designated comprehensive cancer...
8.
Persaud S, Al Hadidi S, Anderson T, Gallagher G, Chimonas S, Korenstein D, et al.
JAMA
. 2024 May;
331(24):2131-2134.
PMID: 38814636
No abstract available.
9.
Xiong L, Pereira De Sa N, Zarnowski R, Huang M, Mota Fernandes C, Lanni F, et al.
PLoS Pathog
. 2024 May;
20(5):e1012225.
PMID: 38739655
Biofilm formation by the fungal pathogen Candida albicans is the basis for its ability to infect medical devices. The metabolic gene ERG251 has been identified as a target of biofilm...
10.
Premarket Evidence and Postmarketing Requirements for Real-Time Oncology Review Indication Approvals
Mooghali M, Mohammad A, Wallach J, Mitchell A, Ross J, Ramachandran R
JAMA Netw Open
. 2024 May;
7(5):e249233.
PMID: 38691363
No abstract available.